While progress has been made, women continue to be underrepresented in clinical trials — affecting treatment protocols and delaying access to lifesaving therapies. This guide examines the historical context, ongoing challenges, and the urgent need for equitable inclusion in oncology...
Women’s health has historically been underrepresented in clinical research, often limited to reproductive endpoints and underfunded across key therapeutic areas. But that landscape is beginning to shift—albeit gradually—as a broader definition of women’s health takes hold, and new avenues for...
The field of women’s oncology is undergoing one of its most transformative periods, driven by the rapid advancement of novel and targeted therapies. Treatment approaches are no longer “one-size-fits-all;” instead, care is increasingly guided by underlying tumor biology, enabling more...